Sigma Healthcare Share Price Update: Little Changed, Up 5.5% in a Month
Technical analysis of Sigma Healthcare stock on November 18, 2026: price 2.90 AUD, trend uptrend, RSI 69.4, support 2.72, resistance 2.91.

Trend & Price Action
The structural picture is cleanly bullish. At 2.90, the stock sits above both the 20-day average at 2.81 and the 50-day average at 2.71, and the shorter average has been climbing, rising 0.73% over the past five days. That combination — price above the 50-day, 20-day above the 50-day, and a rising short-term average — is the textbook definition of an intact uptrend, and no fresh moving-average cross has formed, meaning the trend is established rather than newly minted. The 20-day average is providing a floor roughly 3% below the current price, and that is the level readers should watch if the consolidation breaks lower. The stock is also pressing the top of its three-month envelope. The resistance at 2.91 is one cent away, and the three-month high of 2.95 is just beyond it — conveniently close to the upper Bollinger band. That means the current price is doing exactly what a stock does before it either breaks out or rolls over: testing a ceiling on light participation.
Oscillators & Momentum
Momentum, however, is where the picture gets less comfortable. The RSI at 69.4 sits in what technical traders call the neutral zone but is threading the line just below overbought — a hair under the 70 threshold. More pointedly, the Stochastic is at 84.4 on both %K and %D, which is squarely overbought. For a general reader: these oscillators measure how far and how fast prices have moved, and readings this high mean the rally is getting stretched relative to its own recent history. It is not a sell signal on its own — in strong trends, oscillators can stay pinned high for weeks — but it does mean the easy part of the move has been captured. The counterweight is the MACD, which remains constructive: the MACD line at 0.050 sits above its signal at 0.044, with a positive histogram of 0.007. That is modest but genuine momentum confirmation, and it is not diverging from price. The tension between a positive MACD and an overbought Stochastic is the crux of the setup — the trend is real, but the runway for further immediate gains is short.
Volatility & Volume
Volatility is in the middle of its range. The ATR of 0.05 is 1.7% of the share price, which translates to a stock that moves in modest daily increments, and Bollinger bandwidth of 10.1% is normal — neither a squeeze nor an expansion. The 20-day average slope and the width of the bands together suggest a market that is comfortable, not coiled. The volume line is the story's weak link. Last-session turnover of 10,277,885 shares was just 0.4 times the 20-day average of 23,408,646 — thin, by the data's own description. Thin volume into resistance is a classic warning: breakouts on light participation frequently fail. What keeps the bulls in the argument is the OBV, which continues to rise. On-balance volume tracks cumulative buying pressure, and a rising OBV alongside rising price says the accumulation that drove the 5.45% monthly gain is intact even if today's trade was quiet.Key Levels & Scenarios
The map is straightforward. To the upside, a decisive close above 2.91 opens the path toward the three-month high of 2.95, with the Bollinger upper band in the same neighbourhood. A break above that would require volume to confirm — a breakout on 0.4× average is not a breakout, it is a drift. To the downside, the first line is the 20-day support at 2.72, which coincides closely with the Bollinger middle band at 2.81 and the 20-day average. Losing 2.72 would put the 50-day average at 2.71 in play, and a break there would call the uptrend itself into question.Technical Verdict: BUY
The JournalArta research verdict on this stock is BUY, scored +66 on a −100 to +100 scale, and the reasoning holds up on inspection. Three points carry the call: price is above its 50-day average, the 20-day average is above the 50-day, and the trend is confirmed with RSI in the 50–70 constructive band. The positive MACD histogram and rising OBV reinforce it. The invalidation risk is explicit — the verdict fails if price breaks below the 2.81 stop level, and the overbought Stochastic is the main reason a trader would prefer to enter near the bottom of the range rather than the top.- Entry zone: 2.87 – 2.90
- Exit target 1: 3.03
- Exit target 2: 3.17
- Stop loss: 2.81
- Reward/risk: 1.4 / 3.0 | levels valid until 16 December 2026
This is technical analysis for informational purposes only, not an investment recommendation. Past price behaviour does not guarantee future results.
Why Sigma Healthcare is in focus today
Selected automatically from 9 ASX (Australia) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.
Summary Data Sigma Healthcare
| Last price | 2.90 AUD |
| Change 1 day / 5 days / 1 month | 0.00% / -0.34% / 5.45% |
| Trend / MA-cross | uptrend / none |
| SMA20 / SMA50 | 2.81 / 2.71 |
| RSI (14) / Stochastic %K | 69.4 / 84.4 |
| Bollinger %B / ATR | 81% / 0.05 |
| Support / Resistance 20 days | 2.72 / 2.91 |
| Data as of | 18 November 2026 12:10 WIB |
| JournalArta research verdict (score) | Buy (+66) |
| Entry zone | 2.87 – 2.90 |
| Target 1 / 2 | 3.03 / 3.17 |
| Stop loss | 2.81 |
| Reward/risk | 1.4 / 3.0 |
Today's full Buy and Sell list for Australian stocks (ASX) →
Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.
Track Sigma Healthcare share price daily: live levels, support/resistance and our full Sigma Healthcare analysis history.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →- 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage

- 2Gold Silver Price November: Futures Rise Near Yearly Lows

- 3Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York

- 4GTA 6 New Zealand Time Trick Is Not Guaranteed to Work

- 5Sunrise on the Reaping Reviews Split Over Dark Hunger Games Prequel

Lifestyle · Food & Health4 Reasons to Eat Oatmeal, According to Nutrition Experts
Lifestyle7 Signs Your Social Battery Is Running Low (and Why You Keep Cancelling Plans)
Lifestyle · Food & HealthThanksgiving Food Safety: How Long Leftovers Last and the Safe Turkey Temperature
Lifestyle7 Quiet Habits of Emotionally Intelligent People, According to Psychologists















